ZA802481B - Corticosteroid formulations containing sebacate carrier - Google Patents

Corticosteroid formulations containing sebacate carrier

Info

Publication number
ZA802481B
ZA802481B ZA00802481A ZA802481A ZA802481B ZA 802481 B ZA802481 B ZA 802481B ZA 00802481 A ZA00802481 A ZA 00802481A ZA 802481 A ZA802481 A ZA 802481A ZA 802481 B ZA802481 B ZA 802481B
Authority
ZA
South Africa
Prior art keywords
sebacate
carrier
formulations containing
corticosteroid formulations
corticosteroid
Prior art date
Application number
ZA00802481A
Other languages
English (en)
Inventor
J Hill
Yu Chang John Wang
Chang John Wang Yu
T Wong
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA802481B publication Critical patent/ZA802481B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA00802481A 1979-05-31 1980-04-24 Corticosteroid formulations containing sebacate carrier ZA802481B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/043,989 US4233295A (en) 1979-05-31 1979-05-31 Corticosteroid formulations containing sebacate carrier

Publications (1)

Publication Number Publication Date
ZA802481B true ZA802481B (en) 1981-01-28

Family

ID=21929946

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00802481A ZA802481B (en) 1979-05-31 1980-04-24 Corticosteroid formulations containing sebacate carrier

Country Status (6)

Country Link
US (1) US4233295A (fr)
EP (1) EP0020117A3 (fr)
JP (1) JPS55164626A (fr)
AU (1) AU5774280A (fr)
CA (1) CA1139665A (fr)
ZA (1) ZA802481B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
CH649923A5 (de) * 1980-10-06 1985-06-28 Glaxo Group Ltd Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide.
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US4868168A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid ointment formulation
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4992477A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Skin moisturizing composition and method of preparing same
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US20050002996A1 (en) * 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
US7582307B2 (en) * 2003-11-26 2009-09-01 Harmony Labs, Inc. Dermatological composition
US7897587B2 (en) * 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) * 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
JP6512599B2 (ja) * 2015-03-30 2019-05-15 株式会社池田模範堂 外用医薬組成物
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617653B1 (de) * 1967-09-08 1970-06-18 Meiji Seika Kaisha Indomethacinpraeparat zur externen Anwendung
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
US4048309A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid ointment formulations
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier

Also Published As

Publication number Publication date
US4233295A (en) 1980-11-11
CA1139665A (fr) 1983-01-18
EP0020117A3 (fr) 1981-09-02
EP0020117A2 (fr) 1980-12-10
AU5774280A (en) 1980-12-04
JPS55164626A (en) 1980-12-22

Similar Documents

Publication Publication Date Title
AU534467B2 (en) Carrier powder
GB2063110B (en) Chucking system
GB2057263B (en) Compositions containing methylsulphonylmethane
JPS5597357A (en) Bottle carrier
GB2049840B (en) Bearing carrier
ZA802481B (en) Corticosteroid formulations containing sebacate carrier
DE3068773D1 (en) Bottle carrier
GB2078771B (en) Drug carrier
GB2040348B (en) Holder devices
GB2067176B (en) Demolition-facilitating substance
JPS55143254A (en) Envelop
JPS5650478A (en) Carrier return insertion system
GB2061865B (en) Bottle carrier
GB2063412B (en) Retainer
AU3877478A (en) Holders
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
JPS55108366A (en) Fireeextinguishing substance
PH15118A (en) Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
DE2965703D1 (en) Eyedropper-bottle holder
JPS5657457A (en) Fireeextinguishing substance
ZA813610B (en) Penicillin derivatives,processes for their preparation and compositions containing them
GB2061140B (en) Chucks
GB2066116B (en) Supporting chucks
JPS55103997A (en) Sheettshaped package retainer
JPS5663108A (en) Retainer